 |
|
| Home |
| Download Presentations |
| Conference DVD |
| Take Action Now! |
| Agenda |
| Speakers |
| Location |
| Registration |
| Sponsorships |
Confronting the Epidemic through Nutrition Research and Policy Thursday, June 18 to Friday, June 19, 2009
Presentation Title: Milk and Type 1 Diabetes: The TRIGR Study Objectives:
Outcome: Participants will become informed about research behind the role of early infant nutrition and cow’s milk in the development of type 1 diabetes. Accreditation: Jointly sponsored by The George Washington University and the Physicians Committee for Responsible Medicine. |
| The Web site
does not provide medical or legal advice.
|
Mikael Knip, M.D., Ph.D., is chair of the Hospital for Children and Adolescents and professor of pediatrics at the University of Helsinki, where his research focuses on type 1 diabetes and other immune-mediated diseases in children and adolescents. He is also the principal investigator for two international, multicenter studies. TRIGR (Trial to Reduce IDDM in the Genetically at Risk) is testing the hypothesis that weaning to a highly hydrolyzed formula will reduce the frequency of beta-cell autoimmunity and type 1 diabetes in children at risk. The other study, DIABIMMUNE, researches the hygiene hypothesis in type 1 diabetes and other immune-mediated diseases. Dr. Knip is a member of the Research Council for Health, Academy of Finland, and has served on the scientific review board of the Juvenile Diabetes Research Foundation. He has published more than 350 original papers and 115 scientific articles. Dr. Knip serves on the editorial board of Pediatric Diabetes, and he has served on the editorial boards of the Journal of Clinical Endocrinology and Metabolism and the European Journal of Endocrinology.